research as well as 10-working day monotherapy clinical review with single injections. The antiretroviral activity of Lenacapavir is unaffected by any mutation conferring resistance to more mature antiretrovirals. Lenacapavir is little by little released within the site of injection which involves an Original protection by its oral formulation (hal